Home

Home

High-tech ‘dacha in the woods’ to treat Ukrainian children

The All-Ukrainian Mother and Child Healthcare Centre

UK, France & the Ukraine – In the spring of 2006, Kateryna Yuschenko, Head of the Supervisory Board for the Ukraine 3000 International Charitable Foundation, and wife of the president of Ukraine, laid a capsule at the site of a future hospital — The All-Ukrainian Mother and Child Healthcare Centre.

article image

The All Ukrainian Health Protection Centre for Mothers and Children will cover 10 hectares and contain departments for general paediatrics and surgery (in five surgery blocks), oncology, oncohaematology, and a peritoneal centre. A research and training centre is also planned for paediatric doctors, to help integrate Ukraine into the world medical community

‘Today,’ she said, ‘we make our first step on the way to our greatest dream – building a modern hospital for Ukrainian children, the best of its kind in Europe.’
Following a competition that involved seven architectural companies – based in Germany, Netherlands, Italy, the United Kingdom, USA, and the Ukraine itself – the selected architects for the new 250-bed children’s hospital are bdpgroupe6. ‘The objective is to build a children’s hospital with the most modern medical equipment and to organise a clinic facility that provides specialised, high tech medical care,’ explained Neil Cadenhead, Director of bdpgroupe6. ‘As architects and engineers, we have the ability to design it very sustainably. This appointment confirms that there is a demand for the very best of European hospital design in the international arena.’
The architectural firm BDP, with Groupe6, its associate practice in France, are regularly listed in the BD World Architecture top 10 healthcare architects.  ‘We currently have healthcare buildings in design and construction of a value in excess US $4,527 million in addition to a large international commercial portfolio. The firms are growing and ambitious and have 12 offices in France, the UK and overseas,’ the company reports. ‘Our formalised association as bdpgroupe6 is to undertake international healthcare commissions and we are actively pursuing opportunities throughout the world, often using local collaborators.’
article image

The winning architects designed a highly sustainable building sympathetic to the site, which is in a pretty forest on the edge of Kiev. ‘The new building separates the treatment and diagnostic areas from ward areas and buries the former block beneath a ‘green’ roof so that it merges with the forest floor. The ward blocks were inspired by the Ukrainian tradition of the dacha in the woods, re-interpreted within a modernist aesthetic,’ bdpgroupe6 explained

Construction of the 5-6 floor hospital began last year and will end in 2009. The bdggroupe6 are the architects and structural and environmental engineers. The group is supported by EC Harris as health planners, quantity surveyors and equipment advisors, and by Budova Centre in Kiev - architects engineers and quantity surveyors.

This article was published on 03/01/2008

Search

 

Service

Company News

Accu-Chek® Combo – put effective diabetes management into action

At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.

Insulin in oral capsules

At the international congress on diabetes in September, Oramed Pharmaceuticals, Inc. introduced its oral insulin capsules that might in the future replace injections patients currently have to face. Last week Oramed announced the agreement with ETI Karle Clinical Pvt. Ltd. to conduct phase 2B clinical trials for its oral insulin capsules.